The now of scientific events in rheumatology

By : Global Rheumatology by PANLAR
12 September, 2020
https://doi.org/10.46856/grp.232.e042
views 305Views

License

This is an open-access article distributed by the terms of the Creative Common Attribution License (CC-BY NC-4). The use, distribution or reproduction in other forms is permitted, provided the original author(a) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with this terms.

In 2020, one by one, the scientific events in all areas of knowledge scheduled to take place, on a personal-attendance basis, were gradually cancelled, although most of them were virtually rescheduled, this situation forced a quick adaptation regarding how this type of events should be held. 

While virtuality offers advantages such as simplicity and ease of access, time availability for the contents presented, we are probably witnessing the beginning of a new era regarding how these scientific events will be held. 

 

The impact on medical education, collaborative work and the generation of networks and how has been our capacity for adapting to this scenario, are some of the issues that we will discuss in this episode of a coffee for rheumatology.

Discuss how scientific societies and innovation have evolved with respect to scientific events, what is being done in terms of adaptation of these events and what was the experience of PANLAR.

Today we are joined by Mildred López (ML) Educational Innovation Manager at the School of Medicine and Health Sciences at Tecnológico de Monterrey, Researcher and Innovator in education, PhD in educational innovation. 

Enrique Soriano (ES) Internist, Rheumatologist, President of PANLAR, Researcher, Professor at the Hospital Italiano de Buenos Aires, where he is the head of the Rheumatology Section and active member of the clinical research and virtual education committee. 

 

Hosts

Dr. Diego Jaimes, MD, Podcast Director, Global Rheumatology

Dr. Carlo Vinicio Caballero, Editor-in-Chief, Global Rheumatology

More podcast

Hydroxychloroquine, and old acquaintance that gained strength in the pandemic.

As of December 2019, the COVID-19 epidemic represented one of the major therapeutic challenges…

A look to COVID-19 vaccine from rheumatology

To return to the so-called “new normal” the solution is in a COVID-19 vaccine. In the process…

A coffee for rehumatology

Welcome to A coffee for rheumatology, the podcast of Global Rheumatology by PANLAR (GRP) where…

enviar Envía un artículo